![]() |
市場調查報告書
商品編碼
2024690
體外去心房顫動市場報告:按產品類型、最終用戶和地區分類,2026-2034年External Defibrillators Market Report by Product Type, End User, and Region 2026-2034 |
||||||
2025年,全球體外心臟去心房顫動(AED)市場規模達38億美元。展望未來,IMARC Group預測,到2034年,市場規模將達到69億美元,2026年至2034年的複合年成長率(CAGR)為6.60%。心血管疾病發病率上升、人口老化、政府主導的措施增加以及技術的不斷進步是推動市場成長的主要因素。
體外去心房顫動(EVF)是一種小巧的救生設備,專為治療突發心臟麻痹(SCA)患者而設計。它能分析心率,並透過電擊恢復正常心率。該設備包含電池和用於檢測和分析心電圖的電極片。它還提供語音和視覺指導,從設備開機的那一刻起,即可引導醫護人員完成整個操作過程。此外,非醫護人員也可使用該設備,包括消防員、警察、救生員、空服員、保全、教師、高風險病患的家屬以及一般民眾。
院外心臟麻痹(OHCA)的普遍發生,是由心臟功能機械性喪失和全身循環停止引起的,是成人死亡的主要原因之一,也是推動市場成長的主要動力。此外,不健康的飲食、缺乏運動以及菸酒消費量的增加,導致高血壓、糖尿病和肥胖症患者人數顯著上升。這些中度危險因子可在基層醫療機構進行評估,並提示心臟病發作、中風和其他併發症的風險增加。此外,體外去心房顫動( EVA)擴大安裝在體育設施、購物中心、機場、飛機、公司、會議中心、飯店、學校和辦公室等公共場所。一些去心房顫動配備了兒童衰減系統,可將輸出功率去心房顫動到適合兒童的水平。此外,現代EVA價格實惠、操作簡單且安全。這些因素以及技術的進步,正在對市場產生正面影響。
本報告分析了全球體外心臟去心房顫動市場各細分領域的關鍵趨勢,並對2026年至2034年全球、區域和國家特定市場進行了預測。市場按產品類型和最終用戶進行細分。
本報告也檢視了該行業的競爭格局,並介紹了主要公司,如 BPL Medical Technologies Private Limited、corpuls、CU Medical Germany GmbH、Defibtech LLC、Koninklijke Philips NV、MEDIANA Co. Ltd.、Nihon Kohden Corporation、 檢驗 AG、深展生物科醫療有限公司、Stryker Corporation 和 ZOL
The global external defibrillators market size reached USD 3.8 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 6.9 Billion by 2034, exhibiting a growth rate (CAGR) of 6.60% during 2026-2034. The rising incidence of cardiovascular diseases, expanding aging population, increasing government initiatives, and ongoing technological advancements are primarily driving the market's growth.
External defibrillators are compact, life-saving devices designed to treat individuals experiencing sudden cardiac arrest (SCA). They analyze the heart rhythm and deliver an electric shock to restore normal heart rhythm. They include a battery and pad electrodes necessary for the external defibrillators to detect and interpret an electrocardiogram. They provide voice and visual prompts to guide the healthcare personnel through the entire process from when the device is first switched on. They can also be used by non-medical personnel, including firefighters, police officers, lifeguards, flight attendants, security guards, teachers, family members of high-risk persons, and bystanders.
The widespread prevalence of out-of-hospital cardiac arrest (OHCA) determined by the loss of mechanical cardiac function and the absence of systemic circulation, which is a leading cause of mortality among adults, represents one of the key factors impelling the growth of the market. Moreover, there is a significant rise in the number of people with hypertension, diabetes, and obesity on account of unhealthy diets, physical inactivity, and the increasing consumption of tobacco and alcohol. These intermediate risk factors can be evaluated in primary care facilities and indicate an increased risk of a heart attack, stroke, and other complications. Besides this, external defibrillators are increasingly being kept in public areas, such as sports venues, shopping malls, airports, aircraft, businesses, convention centers, hotels, schools, and offices. Some external defibrillators are equipped with pediatric attenuator systems to reduce the delivered energy to a dose suitable for children. Apart from this, modern external defibrillators are inexpensive, easy to operate, and safe for users. This, coupled with rising technological advancements, is positively influencing the market.
This report provides an analysis of the key trends in each segment of the global external defibrillators market report, along with forecasts at the global, regional and country levels from 2026-2034. The report categorizes the market based on product type and end user.
The competitive landscape of the industry has also been examined along with the profiles of the key players being BPL Medical Technologies Private Limited, corpuls, CU Medical Germany GmbH, Defibtech LLC, Koninklijke Philips N.V., MEDIANA Co. Ltd., Nihon Kohden Corporation, Schiller AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Stryker Corporation and ZOLL Medical Corporation (Asahi Kasei Corporation).